The summary below is from the full report titled “Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial.” It is in the 17 April 2001 issue of Annals of Internal Medicine (volume 134, pages 629-636). The authors are JFE Mann, HC Gerstein, J Pogue, J Bosch, and S Yusuf, for the HOPE Investigators.
Trial of a Drug to Decrease the Risk for Heart Disease in Patients with Mild Kidney Failure. Ann Intern Med. 2001;134:I–96. doi: https://doi.org/10.7326/0003-4819-134-8-200104170-00002
Download citation file:
Published: Ann Intern Med. 2001;134(8):I-96.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use